TrialNCT05814757Phase 2Completed
OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)
Study sponsor: Ocular Therapeutix, Inc. · OCUL
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2024-05-22Actual
Enrollment · participants100Actual
Source updated2024-07-10Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.